Last reviewed · How we verify

tinidazole+fluconazole vs metronidazole+clotrimazole

Université de Sherbrooke · Phase 3 active Small molecule

tinidazole+fluconazole vs metronidazole+clotrimazole is a Nitroimidazole antibiotic, Azole antifungal Small molecule drug developed by Université de Sherbrooke. It is currently in Phase 3 development for Bacterial vaginosis, Vaginal candidiasis.

Tinidazole and fluconazole work by inhibiting the synthesis of DNA and RNA in susceptible fungi and bacteria, respectively.

Tinidazole and fluconazole work by inhibiting the synthesis of DNA and RNA in susceptible fungi and bacteria, respectively. Used for Bacterial vaginosis, Vaginal candidiasis.

At a glance

Generic nametinidazole+fluconazole vs metronidazole+clotrimazole
SponsorUniversité de Sherbrooke
Drug classNitroimidazole antibiotic, Azole antifungal
ModalitySmall molecule
Therapeutic areaInfectious Diseases
PhasePhase 3

Mechanism of action

Tinidazole is a nitroimidazole antibiotic that inhibits DNA synthesis by binding to DNA and causing cross-linking, ultimately leading to cell death. Fluconazole is an azole antifungal that inhibits the synthesis of ergosterol, an essential component of fungal cell membranes, by binding to the enzyme lanosterol 14α-demethylase.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about tinidazole+fluconazole vs metronidazole+clotrimazole

What is tinidazole+fluconazole vs metronidazole+clotrimazole?

tinidazole+fluconazole vs metronidazole+clotrimazole is a Nitroimidazole antibiotic, Azole antifungal drug developed by Université de Sherbrooke, indicated for Bacterial vaginosis, Vaginal candidiasis.

How does tinidazole+fluconazole vs metronidazole+clotrimazole work?

Tinidazole and fluconazole work by inhibiting the synthesis of DNA and RNA in susceptible fungi and bacteria, respectively.

What is tinidazole+fluconazole vs metronidazole+clotrimazole used for?

tinidazole+fluconazole vs metronidazole+clotrimazole is indicated for Bacterial vaginosis, Vaginal candidiasis.

Who makes tinidazole+fluconazole vs metronidazole+clotrimazole?

tinidazole+fluconazole vs metronidazole+clotrimazole is developed by Université de Sherbrooke (see full Université de Sherbrooke pipeline at /company/universit-de-sherbrooke).

What drug class is tinidazole+fluconazole vs metronidazole+clotrimazole in?

tinidazole+fluconazole vs metronidazole+clotrimazole belongs to the Nitroimidazole antibiotic, Azole antifungal class. See all Nitroimidazole antibiotic, Azole antifungal drugs at /class/nitroimidazole-antibiotic-azole-antifungal.

What development phase is tinidazole+fluconazole vs metronidazole+clotrimazole in?

tinidazole+fluconazole vs metronidazole+clotrimazole is in Phase 3.

What are the side effects of tinidazole+fluconazole vs metronidazole+clotrimazole?

Common side effects of tinidazole+fluconazole vs metronidazole+clotrimazole include Diarrhea, Nausea, Abdominal pain, Headache, Dizziness.

Related